Faeth Therapeutics, Inc. Common Stock (NASDAQ: FTH) last traded at $23.25, down 10.68% on the session. The quote above updates while this page is open; the figures below are drawn from Faeth Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Faeth Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker FTH. Its market capitalisation is $600.79 million.
Valuation measures for Faeth Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $600.79M |
|---|---|
| Enterprise value | $583.47M |
| Price / book | 3.47 |
| Beta | 1.81 |
Trailing-twelve-month figures tagged in Faeth Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$195.53M |
| Return on equity | -113.05% |
|---|
| Cash | $26.90M |
|---|
Range and volume for FTH over the past 52 weeks.
| 52-week high | $42.14 |
|---|---|
| 52-week low | $7.45 |
| Volume | 309.8K |
| Average volume | 353.5K |
| Previous close | $26.03 |
Invest a chosen dollar amount in Faeth Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell FTH.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.